TIDMMDC
RNS Number : 6115J
Mediclinic International plc
29 June 2017
Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
South African income tax number: 9950122714
("Mediclinic", the "Company" or the "Group")
29 June 2017
TAX TREATMENT OF ORDINARY SHARE DIVIDEND FOR SHAREHOLDERS ON THE
SOUTH AFRICAN REGISTER
Background
Shareholders on the South African register of the Company are
referred to Mediclinic's announcement of the results for the year
ended 31 March 2017 and declaration of dividend announcement
released on the Stock Exchange News Service and on the Regulatory
News Service on 24 May 2017, confirming that the Board of Directors
of Mediclinic had proposed a final dividend from retained earnings
of 4.70 pence per ordinary share for the year ended 31 March 2017
for approval by the Company's shareholders at the annual general
meeting on Tuesday, 25 July 2017.
The final dividend will be paid on Monday, 31 July 2017 to all
ordinary shareholders who are on the register of members at the
close of business on the record date of Friday, 23 June 2017.
Shareholders on the South African register will be paid the ZAR
cash equivalent of 80.60500 cents (64.48400 cents net of dividend
withholding tax) per share. A dividend withholding tax of 20% will
be applicable to all shareholders on the South African register who
are not exempt therefrom. The ZAR cash equivalent has been
calculated using the following exchange rate: GBP1: ZAR17.15, being
the five-day average ZAR/GBP exchange rate on Friday, 19 May 2017
at 3:00pm GMT Bloomberg.
Tax treatment for shareholders on the South African register
South African tax resident shareholders on the South African
register:
In terms of the Company's Dividend Access Trust structure,
eligible South African tax resident shareholders on the South
African register set out below will receive a component of the
dividend, namely 68.64369 cents per share, from the Dividend Access
Trust and therefore regarded as a local South African dividend,
with the remaining component, namely 11.96131 cents per share,
being received from the Company and therefore regarded as a foreign
non-South African dividend. For purposes of South African dividend
withholding tax, the entire dividend of 80.60500 cents per share is
taxable at a rate of 20%, unless an applicable exemption
applies:
1. in the case of shares held in certificated
form, eligible shareholders who are registered
on the South African register with an
address in South Africa (other than PLC
Nominees Proprietary Limited (or any
successor entity through which shares
held in dematerialised form are held));
and
2. in the case of shares held in dematerialised
form, in respect of whom the South African
transfer secretaries of the Company have
determined, in good faith and by reference
to the information provided to them by
the eligible shareholders and/or their
brokers and/or central securities depository
participants, that such eligible shareholders
are either (i) tax resident in South
Africa or (ii) have an address in South
Africa and have not expressly indicated
that they are not tax resident in South
Africa as at the dividend record date.
Non-South African tax resident shareholders on the South African
register:
Non-South African tax resident shareholders on the South African
register will be paid the dividend by the Company in the usual way
and not through the Dividend Access Trust. The entire dividend of
80.60500 cents per share payable to such shareholders will
therefore be regarded as a foreign dividend and exempt from South
African dividend withholding tax, provided that the relevant
exemption forms have been completed and submitted as
prescribed.
ABOUT MEDICLINIC INTERNATIONAL PLC
Mediclinic is an international private healthcare group with
operating platforms in Southern Africa (South Africa and Namibia),
Switzerland and the United Arab Emirates. Its core purpose is to
enhance the quality of life of patients by providing acute care,
specialist-orientated, multi-disciplinary healthcare services.
Mediclinic also holds a 29.9% interest in Spire Healthcare Group
plc, a LSE listed and UK-based private healthcare group.
Mediclinic comprises 74 hospitals and 37 clinics. Mediclinic
Southern Africa operates 49 hospitals and 2 day clinics throughout
South Africa and 3 hospitals in Namibia with more than 8 000
inpatient beds in total; Hirslanden operates 16 private acute care
facilities and 4 clinics in Switzerland with more than 1 600
inpatient beds; and Mediclinic Middle East operates 6 hospitals and
31 clinics with more than 700 inpatient beds in the United Arab
Emirates.
The platforms' contributions to Group revenue for the financial
year ended 31 March 2017 were 48% by Hirslanden, 28% by Mediclinic
Southern Africa and 24% by Mediclinic Middle East.
During February 2016, the combination of the Company (previously
named Al Noor Hospitals Group plc), with operations mainly in Abu
Dhabi in the United Arab Emirates, and Mediclinic International
Limited was completed. Mediclinic International Limited was a South
African based international private healthcare group founded in
1983 and listed on the JSE, the South African stock exchange, since
1986, with operations in South Africa, Namibia, Switzerland and the
United Arab Emirates (mainly in Dubai). The combination resulted in
the renaming of the enlarged group to Mediclinic International
plc.
Mediclinic has a primary listing on the Main Market of the LSE,
with secondary listings on the JSE in South Africa and the NSX in
Namibia.
For further information, please contact:
Capita Company Secretarial Services Limited
Victoria Dalby
+44 (0)207 954 9600
Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181
Media queries
FTI Consulting
Brett Pollard/Debbie Scott (UK)
+44 (0)20 3727 1000
Frank Ford (South Africa)
+27 (0)21 487 9000
Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH,
United Kingdom
Website: www.mediclinic.com
Corporate broker: Morgan Stanley & Co International plc
JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank
Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
This information is provided by RNS
The company news service from the London Stock Exchange
END
DIVUKUURBSANUAR
(END) Dow Jones Newswires
June 29, 2017 09:00 ET (13:00 GMT)
Mediclinic (LSE:MDC)
Historical Stock Chart
From Apr 2024 to May 2024
Mediclinic (LSE:MDC)
Historical Stock Chart
From May 2023 to May 2024